Literature DB >> 17617813

Doctor--how do I use my EpiPen?

Sam Mehr1, Marnie Robinson, Mimi Tang.   

Abstract

Parents and children who have been prescribed an Epipen are often unable to demonstrate its correct administration. One contributory factor may be that doctors are unfamiliar with the EpiPen and are unable to demonstrate the correct administration of the pen to the family. The aim of this study was to determine the rate of correct EpiPen demonstration by junior and Senior Medical Staff at a major tertiary paediatric Hospital. Junior and Senior medical staff were scored on their ability to correctly use the EpiPen trainer. A 6 step scoring system was used. One-hundred doctors were recruited (Residents n = 31, Senior Residents n = 39, Fellow/Consultants n = 30). Junior and Senior Medical staff had similar scores for EpiPen demonstration, the number that needed to read the EpiPen instructions prior to use and the frequancy of accidental self-injection into the thumb. Only two doctors (2%) demonstrated all 6 administration steps correctly. The most frequent errors made were not holding the pen in place for >5 seconds (57%), failure to apply pressure to activate (21%), and self-injection into the thumb (16%). Ninety five doctors needed to read the instructions, and of these, only 39 (41%) then proceeded to correctly demonstrate the remaining 5 steps. Forty-five doctors had previously dispensed an EpiPen, but only three demonstrated its use to parents/children with a trainer. The majority of doctors do not know how to use an Epipen and are unable to provide appropriate education to parents/children. In 37% of cases, the demonstration would not have delivered adrenaline to a patient.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17617813     DOI: 10.1111/j.1399-3038.2007.00529.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  16 in total

1.  Use of phentolamine in the treatment of Epipen induced digital ischaemia.

Authors:  Jingyuan Xu; Alice Holt
Journal:  BMJ Case Rep       Date:  2012-04-23

2.  Treatment of anaphylaxis: EpiPen, Twinject, or another autoinjector?

Authors:  Alexandre Ackaoui
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

3.  Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject.

Authors:  Stephanie Guerlain; Lu Wang; Akilah Hugine
Journal:  Ann Allergy Asthma Immunol       Date:  2010-12       Impact factor: 6.347

4.  A comparison of 4 epinephrine autoinjector delivery systems: usability and patient preference.

Authors:  Stephanie Guerlain; Akilah Hugine; Lu Wang
Journal:  Ann Allergy Asthma Immunol       Date:  2010-02       Impact factor: 6.347

5.  Management options for accidental injection of epinephrine from an autoinjector: a case report.

Authors:  Christian Mathez; Bernard Favrat; Philippe Staeger
Journal:  J Med Case Rep       Date:  2009-06-08

6.  Oral immunotherapy for food allergy.

Authors:  Mimi L K Tang
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

7.  Demonstration of epinephrine autoinjectors (EpiPen and Anapen) by pharmacists in a randomised, simulated patient assessment: acceptable, but room for improvement.

Authors:  Sandra M Salter; Richard Loh; Frank M Sanfilippo; Rhonda M Clifford
Journal:  Allergy Asthma Clin Immunol       Date:  2014-09-19       Impact factor: 3.406

Review 8.  Adrenaline auto-injectors for the treatment of anaphylaxis with and without cardiovascular collapse in the community.

Authors:  Aziz Sheikh; F Estelle R Simons; Victoria Barbour; Allison Worth
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

9.  Comparison of the robustness and functionality of three adrenaline auto-injectors.

Authors:  Andreas Schwirtz; Harald Seeger
Journal:  J Asthma Allergy       Date:  2012-08-20

10.  Pharmacists' response to anaphylaxis in the community (PRAC): a randomised, simulated patient study of pharmacist practice.

Authors:  Sandra M Salter; Brock Delfante; Sarah de Klerk; Frank M Sanfilippo; Rhonda M Clifford
Journal:  BMJ Open       Date:  2014-07-09       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.